Center for Neurobiology and Behavior, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
J Neurosci. 2013 Sep 4;33(36):14446-54. doi: 10.1523/JNEUROSCI.4804-12.2013.
Accumbal deep brain stimulation (DBS) is a promising therapeutic modality for the treatment of addiction. Here, we demonstrate that DBS in the nucleus accumbens shell, but not the core, attenuates cocaine priming-induced reinstatement of drug seeking, an animal model of relapse, in male Sprague Dawley rats. Next, we compared DBS of the shell with pharmacological inactivation. Results indicated that inactivation using reagents that influenced (lidocaine) or spared (GABA receptor agonists) fibers of passage blocked cocaine reinstatement when administered into the core but not the shell. It seems unlikely, therefore, that intrashell DBS influences cocaine reinstatement by inactivating this nucleus or the fibers coursing through it. To examine potential circuit-wide changes, c-Fos immunohistochemistry was used to examine neuronal activation following DBS of the nucleus accumbens shell. Intrashell DBS increased c-Fos induction at the site of stimulation as well as in the infralimbic cortex, but had no effect on the dorsal striatum, prelimbic cortex, or ventral pallidum. Recent evidence indicates that accumbens DBS antidromically stimulates axon terminals, which ultimately activates GABAergic interneurons in cortical areas that send afferents to the shell. To test this hypothesis, GABA receptor agonists (baclofen/muscimol) were microinjected into the anterior cingulate, and prelimbic or infralimbic cortices before cocaine reinstatement. Pharmacological inactivation of all three medial prefrontal cortical subregions attenuated the reinstatement of cocaine seeking. These results are consistent with DBS of the accumbens shell attenuating cocaine reinstatement via local activation and/or activation of GABAergic interneurons in the medial prefrontal cortex via antidromic stimulation of cortico-accumbal afferents.
伏隔核深部脑刺激 (DBS) 是治疗成瘾的一种有前途的治疗方式。在这里,我们证明,伏隔核壳部的 DBS,但不是核部,可减弱可卡因引发的药物寻求复吸,这是一种动物模型的复发。接下来,我们将壳部的 DBS 与药理学失活进行了比较。结果表明,用影响(利多卡因)或保留(GABA 受体激动剂)传入纤维的试剂进行失活,当将其注入核部而不是壳部时,可阻断可卡因的复吸。因此,壳内 DBS 通过失活该核或穿过它的纤维来影响可卡因复吸的可能性似乎不大。为了检查潜在的全电路变化,使用 c-Fos 免疫组织化学来检查伏隔核壳部 DBS 后的神经元激活。壳内 DBS 增加了刺激部位以及边缘下皮层的 c-Fos 诱导,但对背侧纹状体、前额叶皮层或腹侧苍白球没有影响。最近的证据表明,伏隔核 DBS 逆行刺激轴突末梢,最终激活皮质区域中的 GABA 能中间神经元,这些皮质区域将传入纤维投射到壳部。为了验证这一假设,将 GABA 受体激动剂(巴氯芬/毒蕈碱)在前可卡因复吸前微注射到前扣带皮层、前额叶皮层或边缘下皮层。这三个内侧前额叶皮层亚区的药理学失活均减弱了可卡因寻求的复吸。这些结果与伏隔核壳部的 DBS 通过逆行刺激皮质-伏隔核传入纤维,局部激活和/或激活内侧前额叶皮层中的 GABA 能中间神经元,从而减弱可卡因复吸的假设一致。